Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model

Gut microbiota dysbiosis plays an important role in the progression of non-alcoholic fatty liver disease (NAFLD), and no approved drugs are available for NAFLD treatment. In this study, we aimed to explore the dynamic changes of gut microbiota at the different stages of NAFLD and determine whether u...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hu, Wang, Qingling, Chen, Peizhan, Zhou, Chenghua, Zhang, Xinxin, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685972/
https://www.ncbi.nlm.nih.gov/pubmed/34938193
http://dx.doi.org/10.3389/fphar.2021.788558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685972/
https://www.ncbi.nlm.nih.gov/pubmed/34938193
http://dx.doi.org/10.3389/fphar.2021.788558

Ejemplares similares